Kimberly-Clark Co. (NYSE:KMB - Get Free Report) announced a quarterly dividend on Friday, August 1st, RTT News reports. Shareholders of record on Friday, September 5th will be paid a dividend of 1.26 per share on Thursday, October 2nd. This represents a c) annualized dividend and a dividend yield of 3.9%.
Kimberly-Clark has a dividend payout ratio of 66.0% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Kimberly-Clark to earn $7.88 per share next year, which means the company should continue to be able to cover its $5.04 annual dividend with an expected future payout ratio of 64.0%.
Kimberly-Clark Price Performance
Shares of NYSE KMB traded up $6.02 during trading on Friday, hitting $130.64. 5,386,649 shares of the company were exchanged, compared to its average volume of 2,321,086. The company has a market cap of $43.35 billion, a price-to-earnings ratio of 17.30, a PEG ratio of 4.46 and a beta of 0.35. Kimberly-Clark has a 1 year low of $124.10 and a 1 year high of $150.45. The firm's fifty day moving average price is $131.78 and its 200 day moving average price is $134.53. The company has a debt-to-equity ratio of 7.05, a current ratio of 0.80 and a quick ratio of 0.54.
Kimberly-Clark (NYSE:KMB - Get Free Report) last issued its earnings results on Friday, August 1st. The company reported $1.92 EPS for the quarter, topping the consensus estimate of $1.67 by $0.25. Kimberly-Clark had a net margin of 12.69% and a return on equity of 201.43%. The firm's revenue was down 1.6% compared to the same quarter last year. During the same quarter last year, the company posted $1.96 EPS. On average, sell-side analysts expect that Kimberly-Clark will post 7.5 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research firms recently commented on KMB. JPMorgan Chase & Co. decreased their price objective on shares of Kimberly-Clark from $126.00 to $125.00 and set an "underweight" rating on the stock in a research report on Friday, July 25th. Wall Street Zen lowered shares of Kimberly-Clark from a "buy" rating to a "hold" rating in a research report on Thursday, April 24th. UBS Group decreased their price objective on shares of Kimberly-Clark from $146.00 to $139.00 and set a "neutral" rating on the stock in a research report on Thursday, July 17th. Piper Sandler began coverage on shares of Kimberly-Clark in a research report on Friday, July 18th. They issued an "overweight" rating and a $144.00 price objective on the stock. Finally, Evercore ISI decreased their price objective on shares of Kimberly-Clark from $168.00 to $155.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Two analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $140.90.
Get Our Latest Report on KMB
About Kimberly-Clark
(
Get Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.